110 related articles for article (PubMed ID: 16298621)
1. Development of anti-human leukocyte antigen class 1 antibodies following allogeneic islet cell transplantation.
Lobo PI; Spencer C; Simmons WD; Hagspiel KD; Angle JF; Deng S; Markmann J; Naji A; Kirk SE; Pruett T; Brayman KL
Transplant Proc; 2005 Oct; 37(8):3438-40. PubMed ID: 16298621
[TBL] [Abstract][Full Text] [Related]
2. A significant role for histocompatibility in human islet transplantation.
Mohanakumar T; Narayanan K; Desai N; Ramachandran S; Shenoy S; Jendrisak M; Susskind BM; Olack B; Benshoff N; Phelan DL; Brennan DC; Fernandez LA; Odorico JS; Polonsky KS
Transplantation; 2006 Jul; 82(2):180-7. PubMed ID: 16858280
[TBL] [Abstract][Full Text] [Related]
3. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
4. Different islet protein expression profiles during spontaneous diabetes development vs. allograft rejection in BB-DP rats.
Christensen UB; Larsen PM; Fey S; Karlsen AE; Pociot F; Nerup J; Sparre T
Autoimmunity; 2006 Jun; 39(4):315-21. PubMed ID: 16891220
[TBL] [Abstract][Full Text] [Related]
5. Role of intra-islet endothelial cells in islet allo-immunity.
Bharat A; Saini D; Benshoff N; Goodman J; Desai NM; Chapman WC; Mohanakumar T
Transplantation; 2007 Nov; 84(10):1316-23. PubMed ID: 18049117
[TBL] [Abstract][Full Text] [Related]
6. Pretransplant HLA antibodies are associated with reduced graft survival after clinical islet transplantation.
Campbell PM; Salam A; Ryan EA; Senior P; Paty BW; Bigam D; McCready T; Halpin A; Imes S; Al Saif F; Lakey JR; Shapiro AM
Am J Transplant; 2007 May; 7(5):1242-8. PubMed ID: 17456201
[TBL] [Abstract][Full Text] [Related]
7. Allosensitization of islet allograft recipients.
Cardani R; Pileggi A; Ricordi C; Gomez C; Baidal DA; Ponte GG; Mineo D; Faradji RN; Froud T; Ciancio G; Esquenazi V; Burke GW; Selvaggi G; Miller J; Kenyon NS; Alejandro R
Transplantation; 2007 Dec; 84(11):1413-27. PubMed ID: 18091517
[TBL] [Abstract][Full Text] [Related]
8. Evidence for Induced Expression of HLA Class II on Human Islets: Possible Mechanism for HLA Sensitization in Transplant Recipients.
Jackson AM; Connolly JE; Matsumoto S; Noguchi H; Onaca N; Levy MF; Naziruddin B
Transplantation; 2009 Feb; 87(4):500-6. PubMed ID: 19307785
[TBL] [Abstract][Full Text] [Related]
9. HLA class I sensitization in islet transplant recipients: report from the Collaborative Islet Transplant Registry.
Naziruddin B; Wease S; Stablein D; Barton FB; Berney T; Rickels MR; Alejandro R
Cell Transplant; 2012; 21(5):901-8. PubMed ID: 22080832
[TBL] [Abstract][Full Text] [Related]
10. Is there a risk of sensitizing islet recipients to HLA?
Lum CT; Noreen HJ; Gores P; Dolbec J; Sutherland DE; Segall M
Transplant Proc; 1994 Dec; 26(6):3468. PubMed ID: 7998228
[No Abstract] [Full Text] [Related]
11. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.
Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM
Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764
[TBL] [Abstract][Full Text] [Related]
12. Heart transplantation across antibodies against human leukocyte antigen and ABO-post-transplant follow-up of donor reactive antibodies.
Bućin D; Johansson S; Lindberg LO
Xenotransplantation; 2006 Mar; 13(2):101-4. PubMed ID: 16623800
[TBL] [Abstract][Full Text] [Related]
13. Evidence for allograft rejection in an islet transplant recipient and effect on beta-cell secretory capacity.
Rickels MR; Kamoun M; Kearns J; Markmann JF; Naji A
J Clin Endocrinol Metab; 2007 Jul; 92(7):2410-4. PubMed ID: 17488791
[TBL] [Abstract][Full Text] [Related]
14. Low risk of anti-human leukocyte antigen antibody sensitization after combined kidney and islet transplantation.
Ferrari-Lacraz S; Berney T; Morel P; Marangon N; Hadaya K; Demuylder-Mischler S; Pongratz G; Pernin N; Villard J
Transplantation; 2008 Jul; 86(2):357-9. PubMed ID: 18645502
[TBL] [Abstract][Full Text] [Related]
15. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503
[TBL] [Abstract][Full Text] [Related]
16. Anti-HLA class II antibodies and chronic allograft nephropathy.
Gerbase-DeLima M; Campos EF; Tedesco-Silva H; Machado PG; Franco M; Medina-Pestana JO
Clin Transpl; 2006; ():201-5. PubMed ID: 18365378
[TBL] [Abstract][Full Text] [Related]
17. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
Barocci S; Valente U; Nocera A
Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
[TBL] [Abstract][Full Text] [Related]
18. Characterization of anti-islet cytotoxic human T-cell clones from patients with type 1 diabetes mellitus.
Sobel DO; Creswell K
Autoimmunity; 2006 Jun; 39(4):323-32. PubMed ID: 16891221
[TBL] [Abstract][Full Text] [Related]
19. Identification of Donor Origin and Condition of Transplanted Islets In Situ in the Liver of a Type 1 Diabetic Recipient.
van der Torren CR; Suwandi JS; Lee D; Van't Wout ET; Duinkerken G; Swings G; Mulder A; Claas FH; Ling Z; Gillard P; Keymeulen B; In't Veld P; Roep BO
Cell Transplant; 2017 Jan; 26(1):1-9. PubMed ID: 27729094
[TBL] [Abstract][Full Text] [Related]
20. Sensitization to HLA antigens in islet recipients with failing transplants.
Olack BJ; Swanson CJ; Flavin KS; Phelan D; Brennan DC; White NH; Lacy PE; Scharp DW; Poindexter N; Mohanakumar T
Transplant Proc; 1997 Jun; 29(4):2268-9. PubMed ID: 9193621
[No Abstract] [Full Text] [Related]
[Next] [New Search]
